Approval · Notice of Compliance 23233 · 2020
NUBEQA: Notice of Compliance 23233
Issued February 20, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23233
- Date
- February 20, 2020
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NUBEQA | 02496348 | Marketed |
Medicinal ingredients
- DAROLUTAMIDE 300 MG per TAB